SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0000950170-24-090818
Filing Date
2024-08-05
Accepted
2024-08-05 16:54:10
Documents
16
Effectiveness Date
2024-08-05

Document Format Files

Seq Description Document Type Size
1 S-8 crsp-20240805.htm S-8 119051
2 EX-5.1 crsp-ex5_1.htm EX-5.1 62410
3 EX-23.1 crsp-ex23_1.htm EX-23.1 4355
4 EX-FILING FEES crsp_exfilingfees.htm   iXBRL EX-FILING FEES 33429
5 GRAPHIC img33470342_0.jpg GRAPHIC 20639
  Complete submission text file 0000950170-24-090818.txt   385048

Data Files

Seq Description Document Type Size
18 EXTRACTED XBRL INSTANCE DOCUMENT crsp_exfilingfees_htm.xml XML 8121
Mailing Address BAARERSTRASSE 14 ZUG V8 CH-6300
Business Address BAARERSTRASSE 14 ZUG V8 CH-6300 6173154600
CRISPR Therapeutics AG (Filer) CIK: 0001674416 (see all company filings)

IRS No.: 473173478 | State of Incorp.: V8 | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-281247 | Film No.: 241175702
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)